CTI BioPharma Ratios and Metrics

Market cap in millions ZAR. Fiscal year is April - March.

Millions ZAR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Aug '25 Aug 1, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Market Capitalization	113,137	100,902	113,181	84,278	88,657	41,354	Upgrade
Market Cap Growth	-10.85%	-10.85%	34.29%	-4.94%	114.39%	30.28%	Upgrade
Last Close Price	132.96	113.97	117.45	86.18	80.68	33.82	Upgrade
PE Ratio	7.97	6.82	5.31	5.03	9.67	8.67	Upgrade
PS Ratio	2.39	2.13	2.48	2.13	2.45	1.37	Upgrade
PB Ratio	0.84	0.75	0.87	0.72	0.80	0.38	Upgrade
Debt / Equity Ratio	0.92	0.92	0.94	1.12	1.31	1.36	Upgrade
Return on Equity (ROE)	12.46%	12.46%	12.08%	13.50%	10.07%	5.07%	Upgrade
Return on Assets (ROA)	1.20%	1.20%	1.14%	1.28%	1.01%	0.51%	Upgrade
Earnings Yield	13.07%	16.32%	19.84%	20.93%	11.20%	13.20%	Upgrade
FCF Yield	-24.50%	-27.48%	-37.43%	-58.52%	-46.29%	-10.79%	Upgrade
Dividend Yield	6.43%	7.58%	6.77%	8.13%	6.31%	7.75%	Upgrade
Payout Ratio	56.99%	56.99%	37.67%	37.41%	50.74%	40.84%	Upgrade
Buyback Yield / Dilution	-0.25%	-0.25%	4.64%	2.26%	-0.93%	1.41%	Upgrade
Total Shareholder Return	6.18%	7.33%	11.41%	10.39%	5.38%	9.16%	Upgrade

Source: S&P Global Market Intelligence. Banks template. Financial Sources.